Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T01:08:32.435Z Has data issue: false hasContentIssue false

Cytologic dysplasia after treatment with antimitotic agents

Published online by Cambridge University Press:  01 August 2014

A. Baserga*
Affiliation:
Istituto di Clinica Medica dell'Università di Ferrara

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Antimitotic agents induce pathological alterations by suspension of the normal cellular renewal: it results the picture of the so called « aregenerative pathology ». Moreover, they induce cytological abnormalities, like cellular vacuolization, alterations of the enzymatic cellular pattern, cellular giantism, etc. These alterations constitute the « cytological dysplasia by antimitotic drugs ». They are easily recognizable in many organs, i.e. in the haemopoietic system, lungs and pancreas. Particularly evident is the cellular giantism in the labial epithelia: in some of these cells of gynecologically normal women two Barr bodies are observed.

Type
Research Article
Copyright
Copyright © The International Society for Twin Studies 1967

References

Bibliographie

Baserga, A. (1956). Primi elementi di patologia arigenerativa. Minerva Med. 47: 247.Google Scholar
Baserga, A. (1960). Aregenerative pathology of the digestive tract. Panminerva Med. 2: 457.Google ScholarPubMed
Baserga, A. Marinone, G. (1949). Megamyeloid cells and aminopterin. Lancet 5: 1056.Google Scholar
Baserga, A. Castoldi, G. L. (1966). Sexual chromatin bodies and cytostatics. Lancet 2: 106.Google Scholar